Trial Search Results

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients

The primary aim of this study is to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: phlebotomy

Phase:

N/A

Eligibility


Inclusion Criteria:Inclusion Criteria:Inclusion Criteria (Cases):

   1. Advanced stage (IIIB with malignant effusion or IV) histologically or cytologically
   confirmed NSCLC

   2. Patients must be newly diagnosed (untreated) or have evidence of disease progression
   at the time of sample collection

   3. ability to sign informed consent

   4. at least 18 years of age

Inclusion Criteria (Controls):

   1. no known prior or active malignancy

   2. ability to sign informed consent

   3. at least 18 years of age Exclusion Criteria:1. history of any other cancer other than
   non-melanoma skin cancer within the last 5 years

Exclusion Criteria:1. history of any other cancer other than non-melanoma skin cancer
within the last 5 years

2. pregnant women

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lisa Zhou
650-736-4112
Recruiting